Morgan Health's Dan Mendelson & Oak HC/FT's Vig Chandramouli debate employers vs. consumers transforming healthcare amid AI-driven patient empowerment.
Mirum’s hepatitis D drug brelovitug hits its Phase 3 goal in AZURE-4, setting up a 2027 filing against Gilead’s Hepcludex and ...
White House pushes for Heidi Overton’s FDA confirmation in the lame-duck window, with Cassidy and Murkowski as key votes.
Beam Therapeutics announced Tuesday that its base-edited sickle cell therapy succeeded in a clinical trial, meaning a third ...
Oyster Therapeutics raises $60M Series A-2, with Lilly joining, for self-assembling oral degraders that target toxic tau in ...
FDA approves Bayer’s Sunharbo (asundexian), the first factor XIa inhibitor, to prevent second strokes after a Phase 3 study ...
Congressional Democrats ask all drugmakers with MFN deals for unredacted agreements, setting up subpoena power in January.
Wearable ringmaker Oura is buying AI primary care startup Counsel Health.
The future of ChatGPT Health could be “helping people move from better answers with context to really empowered actions,” Nate Gross, OpenAI's head of health, said in a conversation at Endpoints News’ ...
Third Rock Ventures strikes up to $2.16B antibody discovery deal with Funnel Biosciences, a little-known Chinese AI biotech.
ARPA-H's Advocate program teams met with FDA within 2 months of launch, aiming to submit autonomous AI heart failure devices ...
Zura Bio shares drop ~70% after bispecific tibulizumab fails Ph2 in hidradenitis suppurativa; company drops the drug in HS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results